Muneaki Shimada Selected Research

Muneaki Shimada Research Topics

Disease

41	Neoplasms (Cancer) 09/2022 - 10/2004
32	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2022 - 06/2004
19	Ovarian Neoplasms (Ovarian Cancer) 08/2022 - 02/2002
10	Endometrial Neoplasms (Endometrial Cancer) 05/2022 - 03/2006
9	Carcinoma (Carcinomatosis) 01/2022 - 12/2007
8	Adenocarcinoma 01/2022 - 07/2002
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 07/2013
6	Neoplasm Metastasis (Metastasis) 03/2022 - 02/2013
4	Lymphatic Metastasis 04/2022 - 01/2017
4	Disease Progression 07/2021 - 12/2014
3	Lymphedema (Milroy Disease) 04/2022 - 06/2015
3	Ovarian Epithelial Carcinoma 01/2021 - 07/2011
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 12/2020 - 03/2009
2	Adenosquamous Carcinoma 01/2022 - 11/2019
2	Infections 06/2016 - 02/2002
2	Atrioventricular Block 08/2015 - 08/2012
2	Carcinosarcoma 01/2015 - 12/2014
2	Sarcoma (Soft Tissue Sarcoma) 01/2015 - 12/2014
2	Brain Neoplasms (Brain Tumor) 02/2013 - 02/2005
1	Leiomyosarcoma 01/2022
1	Uterine Neoplasms (Uterine Cancer) 05/2021
1	Vulvar Neoplasms (Vulvar Cancer) 05/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Papillomavirus Infections 12/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020
1	Venous Thromboembolism 01/2020
1	Vomiting 08/2019
1	Anorexia 08/2019
1	Malnutrition (Nutritional Deficiencies) 08/2019
1	Nausea 08/2019
1	Cellulitis 06/2019
1	Lymphocele 06/2019
1	Neoplasm Micrometastasis 06/2019
1	Rupture 01/2019

Drug/Important Bio-Agent (IBA)

13	Paclitaxel (Taxol)FDA LinkGeneric 05/2022 - 03/2004
13	Carboplatin (JM8)FDA LinkGeneric 05/2022 - 10/2008
11	PlatinumIBA 08/2022 - 07/2012
8	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2002
5	taxaneIBA 10/2019 - 01/2012
4	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2017
4	Docetaxel (Taxotere)FDA Link 07/2021 - 03/2004
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2002
3	Irinotecan (Camptosar)FDA LinkGeneric 06/2016 - 03/2012
3	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2014 - 12/2007
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2022 - 01/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2022 - 01/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2022 - 11/2017
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2017
2	pazopanib FDA Link 03/2016 - 10/2014
2	SugammadexIBA 08/2015 - 08/2012
2	dactolisibIBA 08/2014 - 03/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2014 - 07/2011
2	nedaplatinIBA 01/2013 - 07/2012
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 07/2012 - 12/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2012 - 12/2007
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 07/2012 - 12/2007
1	olaparibIBA 08/2022
1	Epirubicin (Ellence)FDA LinkGeneric 05/2022
1	AnthracyclinesIBA 05/2022
1	RNA (Ribonucleic Acid)IBA 04/2022
1	niraparibIBA 01/2022
1	Matrix Metalloproteinase 10 (Stromelysin 2)IBA 01/2022
1	Poly Adenosine Diphosphate RiboseIBA 01/2022
1	Circulating Tumor DNAIBA 11/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	Coloring Agents (Dyes)IBA 05/2021
1	Radioisotopes (Radionuclides)IBA 05/2021
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 06/2020
1	Biological ProductsIBA 06/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Gemcitabine FDA Link 10/2019
1	liposomal doxorubicin (Doxil)FDA Link 10/2019
1	Capsules (Microcapsules)IBA 01/2019

Therapy/Procedure

33	Drug Therapy (Chemotherapy) 04/2022 - 10/2004
30	Hysterectomy 09/2022 - 06/2004
23	Therapeutics 09/2022 - 02/2002
13	Radiotherapy 04/2022 - 02/2013
12	Lymph Node Excision (Lymph Node Dissection) 04/2022 - 06/2004
5	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 03/2009
5	Neoadjuvant Therapy 12/2020 - 04/2014
4	Adjuvant Radiotherapy 03/2022 - 06/2004
3	Adjuvant Chemotherapy 05/2022 - 03/2016
3	Cytoreduction Surgical Procedures 01/2020 - 12/2003
3	Salpingo-oophorectomy 11/2017 - 05/2006
2	Chemoradiotherapy 12/2020 - 05/2020
2	Palliative Care (Palliative Therapy) 10/2016 - 06/2016
2	General Anesthesia 08/2013 - 10/2004
1	Minimally Invasive Surgical Procedures 03/2022
1	Brachytherapy 03/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 05/2020
1	Perioperative Period 01/2020
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 01/2020
1	Laparotomy 01/2019
1	Ovariectomy (Oophorectomy) 01/2018